Diagnostic Criteria and Assessment for Psoriatic Arthritis

Classification Criteria

• The CASPAR classification criteria (endorsed by the American Academy of Dermatology) require established inflammatory arthritis (tender + swollen joints with prolonged morning stiffness) plus ≥ 3 points from specific clinical features, achieving 98.7 % specificity and 91.4 % sensitivity【1】.

• Current psoriasis contributes 2 points toward the CASPAR score (American Academy of Dermatology)【2】.

Clinical Examination

• Perform a 68‑tender/66‑swollen joint count that includes the distal interphalangeal (DIP) joints of the hands and the proximal/distal interphalangeal joints of the feet; DIP involvement is characteristic of PsA and uncommon in rheumatoid arthritis【3】.

• Dactylitis (“sausage digit”) is common in PsA but rare in rheumatoid arthritis and should be actively sought (American Academy of Dermatology)【1】.

• Systematically examine for enthesitis at typical sites (plantar fascia, Achilles tendon, rib, spinal and pelvic ligament insertions) (American Academy of Dermatology)【4】.

• Conduct a thorough skin and nail assessment; nail dystrophy (pitting, onycholysis, hyperkeratosis) is especially prevalent in patients with DIP joint disease (American Academy of Dermatology)【1】.

• Document the pattern of joint involvement: usually asymmetric, with DIP joint involvement and generally less tender/swollen joints than seen in rheumatoid arthritis (American Academy of Dermatology)【5】.

Laboratory Evaluation

• No single serologic test definitively diagnoses PsA; the diagnosis remains clinical (American Academy of Dermatology)【1】.

• Rheumatoid factor (RF) is negative in the majority of PsA patients; however, 5–13 % may be RF‑positive, so a positive RF does not exclude PsA when other features are present (American Academy of Dermatology)【1】.

• Acute‑phase reactants (ESR/CRP) are elevated in approximately 50 % of patients; an elevated ESR is linked to a higher risk of radiographic damage progression (American Academy of Dermatology)【6】.

Imaging

• Plain radiography should be obtained to identify the characteristic combination of destructive changes (erosions, tuft resorption, osteolysis) and bone proliferative features (periostitis, ankylosis, spur formation, non‑marginal syndesmophytes) (American Academy of Dermatology)【1】.

• Radiographs also delineate the extent and anatomical distribution of joint disease and can reveal asymptomatic axial involvement (spine or sacroiliac joints) when axial disease is suspected (American Academy of Dermatology)【5】.

Baseline Assessment Domains (OMERACT 8 Consensus)

• Peripheral joint assessment using the 68‑tender/66‑swollen joint count (OMERACT)【6】.
• Patient‑reported pain measured on a visual analogue or categorical rating scale (OMERACT)【7】.
• Patient global assessment of disease activity (OMERACT)【7】.
• Physical function evaluated with the Health Assessment Questionnaire (HAQ) (OMERACT)【3】.
• Health‑related quality of life using SF‑36 or PsAQoL (OMERACT)【4】.
• Fatigue assessment via patient self‑report or FACIT (OMERACT)【7】.
• Radiographic assessment performed according to clinical presentation and physician judgment (OMERACT)【3】.

Differential Diagnosis

• Compared with rheumatoid arthritis, PsA shows less symmetric joint distribution, frequent DIP involvement, presence of dactylitis and enthesitis, absence of rheumatoid nodules and high‑titer RF, and characteristic skin/nail findings (American Academy of Dermatology; OMERACT)【3】.

• Female patients with PsA may present a symmetric polyarticular pattern resembling RA in about 20 % of cases; skin and nail examination are essential for correct differentiation (American Academy of Dermatology)【5】.

Multidisciplinary Confirmation and Screening

• Diagnosis should ideally be confirmed jointly by a dermatologist (verifying psoriasis) and a rheumatologist (confirming inflammatory musculoskeletal disease), or by any appropriately qualified health professional (OMERACT; American Academy of Dermatology)【3】.

• Dermatologists should screen for PsA at every visit; 84 % of PsA patients had cutaneous disease for an average of 12 years before arthritis onset (American Academy of Dermatology)【2】.

• Early referral to rheumatology is advised when the dermatologist is uncomfortable with evaluation or treatment, as prompt diagnosis and therapy are critical to prevent persistent inflammation, joint damage, and disability (American Academy of Dermatology)【2】.

Common Pitfalls

• Do not assume that skin disease severity correlates with arthritis severity; the two often do not correlate (American Academy of Dermatology)【4】.

• Do not exclude PsA solely on a negative RF result; PsA is a seronegative spondyloarthropathy and occasional RF positivity occurs (American Academy of Dermatology)【1】.

• Do not overlook nail examination; nail disease is common, especially in patients with DIP joint involvement (American Academy of Dermatology)【1】.

• Ask specifically about prolonged morning stiffness lasting >30 minutes; this is a valuable screening question for all psoriasis patients (American Academy of Dermatology)【8】.

Diagnostic Criteria and Assessment for Psoriatic Arthritis

Clinical Diagnostic Criteria

• The American Academy of Dermatology (AAD) recommends using the CASPAR classification, which requires established inflammatory arthritis (tender/swollen joints with prolonged morning stiffness) plus ≥ 3 points from specific clinical features; this yields a specificity of 98.7 % and sensitivity of 91.4 %【@1】.
• Current dactylitis or a documented history of dactylitis by a rheumatologist contributes 1 point toward the CASPAR score【@4】.
• Psoriatic nail dystrophy (e.g., onycholysis, pitting, hyperkeratosis) contributes 1 point toward the CASPAR score【@4】.

Laboratory Evaluation

• No single serologic test can definitively diagnose PsA; the diagnosis remains clinical (AAD)【@1】.
• Rheumatoid factor (RF) is typically negative in PsA, although 5‑13 % of patients may be RF‑positive【@1】.
• Acute‑phase reactants (ESR/CRP) are elevated in only about 50 % of patients; an elevated ESR is associated with a higher risk of radiographic damage progression (moderate evidence)【@6】.

Imaging Modalities

Plain Radiography

• Radiographs reveal a combination of destructive changes (erosions, tuft resorption, osteolysis) and bone proliferative features (periostitis, ankylosis, spur formation, non‑marginal syndesmophytes) (AAD)【@1】.
• Imaging demonstrates the extent and anatomical distribution of joint involvement (AAD)【@1】.
• For suspected axial disease, radiographs, MRI, or CT can detect asymptomatic spine or sacroiliac involvement (AAD)【@1】.

Ultrasound (Power Doppler)

• The American College of Radiology (ACR) states that ultrasound is superior to clinical examination for detecting both inflammation and structural damage in PsA (high‑quality evidence)【@8】.
• Ultrasound can identify synovial hypertrophy, hyperemia, erosions, and enthesitis (ACR)【@8】.
• The presence of erosions, synovial hypertrophy, and hyperemia raises the post‑test probability of inflammatory arthritis to 50‑94 % (moderate evidence)【@8】.
• Isolated mild synovial hypertrophy is nonspecific and has limited diagnostic relevance (moderate evidence)【@8】.

Magnetic Resonance Imaging (MRI)

• MRI with intravenous gadolinium is more sensitive than ultrasound, particularly for early disease (moderate‑high evidence)【@8】.
• MRI detects bone‑marrow edema and synovitis, both of which predict disease progression (moderate evidence)【@8】.
• Current data are inconclusive regarding overall superiority of MRI versus ultrasound (low‑moderate evidence)【@8】.

Physical Examination Findings

• A comprehensive joint count assesses 68 tender and 66 swollen joints, including distal interphalangeal (DIP) joints of the hands and proximal/distal interphalangeal joints of the feet (AAD)【@4】.
• Dactylitis (sausage‑shaped digit) is common in PsA and uncommon in rheumatoid arthritis (AAD)【@1】.
• Examination of skin and nails for psoriatic plaques, nail pitting, onycholysis, and hyperkeratosis is essential (AAD)【@1】.
• Typical joint involvement pattern in PsA is asymmetric, frequently involves DIP joints, and is generally less tender/swollen than in rheumatoid arthritis (AAD)【@1】.

Baseline Assessment Measures

• At baseline, record the peripheral joint count (68/66), patient‑reported pain on a visual analogue scale, patient global disease activity, physical function using the Health Assessment Questionnaire, health‑related quality of life (SF‑36 or PsAQoL), and fatigue assessment (Annals of the Rheumatic Diseases)【@7】.

Differential Diagnosis

• Compared with rheumatoid arthritis, PsA shows less symmetric joint distribution, DIP involvement, dactylitis, and enthesitis; it lacks rheumatoid nodules and high‑titer RF, and it presents with characteristic skin/nail findings (AAD)【@4】.
• Compared with osteoarthritis, PsA features inflammatory joint swelling rather than osteophyte‑driven Heberden’s nodes; inflammatory swelling improves with activity, whereas OA pain worsens (AAD)【@9】.

Pediatric Uveitis Screening

• In pediatric PsA, the prevalence of uveitis ranges from 1.5 % to 25 %; screening should include history and ophthalmologic examination for eye pain, redness, visual loss, or photophobia (AAD)【@10】.

Multidisciplinary Confirmation

• The AAD and the Annals of the Rheumatic Diseases recommend that suspected PsA be confirmed jointly by a dermatologist (to verify psoriasis) and a rheumatologist (to confirm inflammatory musculoskeletal disease)【@6】.

Diagnostic Criteria and Clinical Assessment for Psoriatic Arthritis

Classification (CASPAR) Criteria

• The Classification of Psoriatic Arthritis (CASPAR) requires established inflammatory arthritis plus ≥ 3 points from specific clinical features, achieving 98.7 % specificity and 91.4 % sensitivity for PsA classification【9】.
• Points are allocated as follows: current psoriasis = 2 points; personal history of psoriasis = 1 point; family history of psoriasis = 1 point; dactylitis = 1 point; juxta‑articular new bone formation on radiographs = 1 point; rheumatoid‑factor negativity = 1 point; typical psoriatic nail dystrophy = 1 point【9】.

Clinical Examination

• Joint involvement in PsA is typically asymmetric, with less tenderness and swelling than seen in rheumatoid arthritis【9】.
• Dactylitis (“sausage digit”) is common in PsA and rare in rheumatoid arthritis【9】.
• Systematic assessment for enthesitis (e.g., plantar fascia, Achilles tendon, rib, spinal and pelvic insertions) is recommended【9】.
• Nail changes—pitting, onycholysis, hyperkeratosis—are especially prevalent when distal interphalangeal (DIP) joints are affected【9】.
• Current psoriatic skin plaques score 2 points, making skin disease the highest‑weighted CASPAR feature【9】.
• A morning stiffness lasting >30 minutes is a valuable screening question for all patients with psoriasis【9】.
• Visible joint erythema, warmth, and swelling indicate active inflammation【10】.

Laboratory Evaluation

• No single serologic test definitively diagnoses PsA; the diagnosis remains primarily clinical【9】.
• Rheumatoid‑factor negativity contributes 1 point to CASPAR, but 5–13 % of PsA patients may be RF‑positive, so a positive RF does not exclude PsA【9】.
• Acute‑phase reactants (ESR/CRP) are elevated in roughly 50 % of patients; an elevated ESR is linked to a higher risk of radiographic damage progression【10】.

Imaging Assessment

• Plain radiographs should be obtained to identify the characteristic combination of destructive changes (erosions, tuft resorption, osteolysis) and bone‑proliferative features (periostitis, ankylosis, spur formation, non‑marginal syndesmophytes)【9】.
• Radiographs also delineate disease extent and can reveal asymptomatic axial involvement (spine or sacroiliac joints)【9】.

Baseline Assessment Domains (OMERACT 8 Consensus)

• At initial evaluation, document:

Differential Diagnosis: PsA vs. Rheumatoid Arthritis

• PsA shows less symmetric joint distribution compared with RA【9】.
• Frequent DIP joint involvement is characteristic of PsA and uncommon in RA【9】.
• Presence of dactylitis and enthesitis favors PsA; these features are rare in RA【9】.
• Absence of rheumatoid nodules and typically negative high‑titer RF in PsA distinguishes it from RA【9】.
• Skin and nail findings (psoriasis plaques, nail dystrophy) are hallmark features of PsA【9】.
• Approximately 20 % of PsA patients—particularly women—may present with a symmetric polyarticular pattern resembling RA; careful skin and nail examination remains essential for differentiation【9】.

Multidisciplinary Confirmation & Referral

• Optimal diagnosis should be jointly confirmed by a dermatologist (verifying psoriasis) and a rheumatologist (confirming inflammatory musculoskeletal disease)【10】.
• Early referral to rheumatology is advised when the dermatologist is uncertain, as prompt diagnosis prevents persistent inflammation, progressive joint damage, and disability【9】.